These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
370 related items for PubMed ID: 17238139
1. Deciphering the underlying genetic and epigenetic events leading to gastric carcinogenesis. Vogiatzi P, Vindigni C, Roviello F, Renieri A, Giordano A. J Cell Physiol; 2007 May; 211(2):287-95. PubMed ID: 17238139 [Abstract] [Full Text] [Related]
2. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications. Sigalotti L, Fratta E, Coral S, Cortini E, Covre A, Nicolay HJ, Anzalone L, Pezzani L, Di Giacomo AM, Fonsatti E, Colizzi F, Altomonte M, Calabrò L, Maio M. J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893 [Abstract] [Full Text] [Related]
3. Epigenetic drugs take on cancer. Kaiser J. Science; 2010 Oct 29; 330(6004):576-8. PubMed ID: 21030620 [No Abstract] [Full Text] [Related]
4. Novel approaches on epigenetics. Papait R, Monti E, Bonapace IM. Curr Opin Drug Discov Devel; 2009 Mar 29; 12(2):264-75. PubMed ID: 19333872 [Abstract] [Full Text] [Related]
5. Innovative approaches to the clinical development of DNA methylation inhibitors as epigenetic remodeling drugs. Murgo AJ. Semin Oncol; 2005 Oct 29; 32(5):458-64. PubMed ID: 16210086 [Abstract] [Full Text] [Related]
6. Epi-drugs to fight cancer: from chemistry to cancer treatment, the road ahead. Mai A, Altucci L. Int J Biochem Cell Biol; 2009 Jan 29; 41(1):199-213. PubMed ID: 18790076 [Abstract] [Full Text] [Related]
7. Epigenetic biomarkers for human cancer: the time is now. Mulero-Navarro S, Esteller M. Crit Rev Oncol Hematol; 2008 Oct 29; 68(1):1-11. PubMed ID: 18430583 [Abstract] [Full Text] [Related]
8. DNA demethylating agents and epigenetic therapy of cancer. Mani S, Herceg Z. Adv Genet; 2010 Oct 29; 70():327-40. PubMed ID: 20920754 [Abstract] [Full Text] [Related]
9. Epigenetic regulation: a new research area for melatonin? Korkmaz A, Reiter RJ. J Pineal Res; 2008 Jan 29; 44(1):41-4. PubMed ID: 18078446 [Abstract] [Full Text] [Related]
12. Epigenetic therapy using the histone deacetylase inhibitor for increasing therapeutic gain in oral cancer: prevention of radiation-induced oral mucositis and inhibition of chemical-induced oral carcinogenesis. Chung YL, Lee MY, Pui NN. Carcinogenesis; 2009 Aug 29; 30(8):1387-97. PubMed ID: 19351790 [Abstract] [Full Text] [Related]
13. Targeting aberrant chromatin structure in colorectal carcinomas. Konishi K, Issa JP. Cancer J; 2007 Aug 29; 13(1):49-55. PubMed ID: 17464246 [Abstract] [Full Text] [Related]
16. Epigenetic therapy in cancer: molecular background and clinical development of histone deacetylase and DNA methyltransferase inhibitors. Schneider-Stock R, Ocker M. IDrugs; 2007 Aug 29; 10(8):557-61. PubMed ID: 17665331 [Abstract] [Full Text] [Related]
17. Epigenome: a new target in cancer therapy. Giacinti L, Vici P, Lopez M. Clin Ter; 2008 Aug 29; 159(5):347-60. PubMed ID: 18998037 [Abstract] [Full Text] [Related]
18. Epigenetic therapies reach main street. Bates SE. Clin Cancer Res; 2009 Jun 15; 15(12):3917. PubMed ID: 19528089 [No Abstract] [Full Text] [Related]
19. Stomach - Genetic and epigenetic alterations of preneoplastic and neoplastic lesions. David S, Meltzer SJ. Cancer Biomark; 2010 Jun 15; 9(1-6):493-507. PubMed ID: 22112492 [Abstract] [Full Text] [Related]
20. Epigenetic alterations and cancer: new targets for therapy. Allen A. IDrugs; 2007 Oct 15; 10(10):709-12. PubMed ID: 17899489 [Abstract] [Full Text] [Related] Page: [Next] [New Search]